6-Octen-1-ol, 3,7-dimethyl-, acetate, (3S)-
| Common Name: |
6-Octen-1-ol, 3,7-dimethyl-, acetate, (3S)- |
| IUPAC Name: |
[(3S)-3,7-dimethyloct-6-enyl] acetate |
| Molecular Formula: |
C7H14O3 |
| SMILES: |
CC(CCC=C(C)C)CCOC(=O)C |
| Inchi: |
1S/C12H22O2/c1-10(2)6-5-7-11(3)8-9-14-12(4)13/h6,11H,5,7-9H2,1-4H3/t11-/m0/s1 |
| Inchi Key: |
JOZKFWLRHCDGJA-NSHDSACASA-N |
| Cas No: |
67601-05-2 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
2 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
146.18 |
| Mass (g/mol) |
198.162 |
| Molar Refractivity |
38.21 |
| Net Charge |
|
| HBD |
1 |
| HBA |
3 |
| Rt Bonds |
5 |
| Rings |
|
| TPSA |
46.53 |
| Hetero Atoms |
2 |
| Heavy Atoms |
10 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
258.00 to 259.00 |
| Vapor Pressure (mmHg@25.00 °C) |
0.01 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.86 |
| LogP |
3.322 |
| iLOGP |
2.06 |
| XLOGP3 |
1.12 |
| WLOGP |
0.71 |
| MLOGP |
0.75 |
| ESOL Log S |
-1.12 |
| ESOL Solubility (mg/ml) |
11 |
| ESOL Solubility (mol/l) |
0.076 |
| ESOL Class: esol_class |
Very soluble |
| Ali Log S |
-1.69 |
| Ali Solubility (mg/ml) |
2.98 |
| Ali Solubility (mol/l) |
0.02 |
| Ali Class |
Very soluble |
| Silicos-IT LogSw |
-1.01 |
| Silicos-IT Solubility (mg/ml) |
14.3 |
| Silicos-IT Solubility (mol/l) |
0.1 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-6.40 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.745 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
1.576 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
